Physician profile
Nirav Parekh
NPI 1053687053
$27,522.11
in general payments reported to CMS, 2019-2025
23 companies · $729 in 2025
The $729 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $8,412 · 2021: $4,088 · 2022: $1,413 · 2023: $962 · 2024: $703 · 2025: $729.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,393.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $24,541.42 | 2019-2025 | Wavewriter Alpha Prime 16, General - Therapies, Patient Trial Kit |
| Nevro Corp. | $1,138.00 | 2019-2023 | Senza |
| Medtronic USA, INC. | $782.07 | 2019-2020 | |
| Pfizer INC. | $203.11 | 2019-2020 | |
| Amgen INC. | $199.28 | 2020-2023 | Enbrel, Tavneos, Otezla |
| Abbott Laboratories | $101.15 | 2019-2020 | |
| Avanos Medical | $100.55 | 2020-2025 | Standard Rf Disposables, Coolief* Cooled Radiofrequency |
| Si-Bone, INC. | $83.33 | 2019-2024 | |
| Globus Medical, INC. | $60.79 | 2025 | Senza |
| Vertos Medical, INC. | $56.70 | 2020-2022 | |
| Fresenius Kabi USA, LLC | $34.55 | 2023-2024 | Idacio |
| Stryker Corporation | $27.25 | 2024 | Multigen 2 |
| Novartis Pharmaceuticals Corporation | $23.94 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.17 | 2021 | |
| Spr Therapeutics, INC | $18.98 | 2025 | Sprint Pns System |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $18.71 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.74 | 2023 | |
| Ani Pharmaceuticals, INC. | $17.13 | 2024 | Purified Cortrophin Gel |
| Bioventus LLC | $17.04 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $16.21 | 2025 | |
| Ucb, INC. | $16.20 | 2021 | |
| Fidia Pharma USA INC. | $14.13 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nirav Parekh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.